NRx Pharmaceuticals Announces Definitive Purchase Agreement for Preferred Shares at $0.40 per share
/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced...